Aframend
Ogbomoso
About Aframend
Aframend is a biotech startup revolutionizing drug discovery by harnessing artificial intelligence to make advanced pharmaceutical research accessible and efficient, especially for Africa’s unique healthcare challenges.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Non-Equity Assistance (May 2025)
- Website: aframend.com.ng
Industries & Categories
Artificial Intelligence (AI), Pharmaceutical
Canonical: https://fsome.com/organization/aframend-2809743 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.